These findings suggest that the simultaneous regulation of proapoptotic Bcl-2 and antiapoptotic IAP proteins is a key mechanism in the sensitization of pancreatic cancer cells to TRAIL. The gene discussed is BCL2; the disease is familial pancreatic carcinoma.